<?xml version="1.0" encoding="ISO-8859-1"?>

<!DOCTYPE rss PUBLIC "-//Netscape Communications//DTD RSS 0.91//EN"
 "http://my.netscape.com/publish/formats/rss-0.91.dtd">

<rss version="0.91">

<channel>
<title>Slovensk&amp;yacute; hematolologick&amp;yacute; port&amp;aacute;l</title>
<link>http://www.hematology.sk</link>
<description>prv&amp;yacute; slovensk&amp;yacute; hematologick&amp;yacute; port&amp;aacute;l</description>
<language>en-us</language>

<item>
<title>Skupinov&eacute; povolenie na lie&egrave;bu MDS Revlimidom</title>
<link>http://www.hematology.sk/modules.php?name=News&amp;file=article&amp;sid=522</link>
<description>&lt;b&gt;Ministerstvo zdravotn&iacute;ctva Slovenskej republiky &lt;/b&gt;&lt;/br&gt;
povol'uje použitie &lt;b&gt;120 balen&iacute; lieku Revlimid cps 21x10 mg&lt;/b&gt; v neregistrovanej indik&aacute;cii na lie&egrave;bu MDS s cytogenetickou aber&aacute;ciou del 5q&lt;/br&gt;

</description>
</item>

<item>
<title>Povolenie na použ&iacute;vanie interferonov pre MPO</title>
<link>http://www.hematology.sk/modules.php?name=News&amp;file=article&amp;sid=521</link>
<description>&lt;b&gt;MZd SR vyd&aacute;va&lt;/b&gt;&lt;/br&gt;
&lt;/br&gt;
skupinov&eacute; povolenie s platnosťou do 31.7.2012 na použitie interferonov v neregistrovan&yacute;ch indik&aacute;ciach:&lt;/br&gt;
</description>
</item>

<item>
<title>Haemocompletan P</title>
<link>http://www.hematology.sk/modules.php?name=News&amp;file=article&amp;sid=520</link>
<description>&lt;b&gt;MZd SR vyd&aacute;va&lt;/b&gt;&lt;/br&gt;
&lt;/br&gt;
skupinov&eacute; povolenie s platnosťou do 31.7.2012 na použitie neregistrovan&eacute;ho lieku Haemocompletan 1g, Identifika&egrave;n&yacute; k&oacute;d: MD037&lt;/br&gt;</description>
</item>

<item>
<title>Program odborn&yacute;ch podujat&iacute; SHaTS v roku 2012</title>
<link>http://www.hematology.sk/modules.php?name=News&amp;file=article&amp;sid=519</link>
<description>&lt;b&gt;Odborn&eacute; podujatia 2012&lt;/b&gt;&lt;/br&gt;
&lt;/br&gt;
Na z&aacute;klade uznesenia v&yacute;boru HaTS SLS o redukcii po&egrave;tu odborn&yacute;ch sponzorovan&yacute;ch podujat&iacute; v roku 2012, ich unifik&aacute;cie a “kumul&aacute;cie“ bola zvolan&aacute; sch&ocirc;dza z&aacute;stupcov sponzoruj&uacute;cich firiem, d&ograve;a 16.11.2011, (na O&Uacute;SA Bratislava) za &uacute;&egrave;asti z&aacute;stupcov firiem: Amgen, AOP-Orphan, Celgen, Janssen, Mundipharma, Novartis a prezidenta HaTS SLS&lt;/br&gt;</description>
</item>

<item>
<title>Povolenie na terapeutick&eacute; použitie neregistrovan&yacute;ch liekov</title>
<link>http://www.hematology.sk/modules.php?name=News&amp;file=article&amp;sid=518</link>
<description>MZd SR vyd&aacute;va&lt;/br&gt;
&lt;/br&gt;
&lt;b&gt;Povolenie na terapeutick&eacute; použitie neregistrovan&yacute;ch liekov&lt;/b&gt;&lt;/br&gt;
&lt;/br&gt;
platnosť povolenia do 30.6.2012&lt;/br&gt;</description>
</item>

<item>
<title>Videopredn&aacute;šky na t&eacute;mu hematoonkol&oacute;gia</title>
<link>http://www.hematology.sk/modules.php?name=News&amp;file=article&amp;sid=517</link>
<description>&lt;b&gt;HEMATOONKOL&Oacute;GIA&lt;/b&gt;&lt;/br&gt;
&lt;/br&gt;
Sekce videop&oslash;edn&aacute;šky z hematoonkologie obsahuje webcasty z nejd&ugrave;ležit&igrave;jš&iacute;ch kongres&ugrave;, semin&aacute;&oslash;&ugrave; a symp&oacute;zi&iacute;. Na &uacute;vod jsme pro V&aacute;s p&oslash;ipravili z&aacute;znamy ze  satelitn&iacute;ho symp&oacute;zia konan&eacute;ho u p&oslash;&iacute;ležitosti XXIV. Olomouck&yacute;ch hematologick&yacute;ch dn&ugrave; s mezin&aacute;rodn&iacute; &uacute;&egrave;ast&iacute;.


</description>
</item>

<item>
<title>Novinky v lie&egrave;be lymfoprolifer&aacute;ci&iacute;</title>
<link>http://www.hematology.sk/modules.php?name=News&amp;file=article&amp;sid=516</link>
<description>&lt;b&gt;V&yacute;sledky klinick&yacute;ch studi&iacute;:m&igrave;n&iacute; naš&iacute; klinickou praxi?&lt;/b&gt;&lt;/br&gt;
&lt;/br&gt;
VIDEOPREZENT&Aacute;CIA&lt;/br&gt;
&lt;/br&gt;
07.02.2011&lt;/br&gt;
MUDr. Zuzana Kubov&aacute;, Hemato-onkologick&aacute; klinika FN Olomouc&lt;/br&gt;
MUDr. V&iacute;t Proch&aacute;zka, Hemato-onkologick&aacute; klinika FN Olomouc&lt;/br&gt;
MUDr. Peter Turcs&aacute;nyi, Hemato-onkologick&aacute; klinika, FN Olomouc&lt;/br&gt;
&lt;/br&gt;
P&oslash;edn&aacute;ška odezn&igrave;la na 7. Moravsk&eacute;m Lymfomov&eacute;m Symposiu v Olomouci 28. ledna 2011.
</description>
</item>

<item>
<title>Fyziologie erytropoezy a metabolismus železa</title>
<link>http://www.hematology.sk/modules.php?name=News&amp;file=article&amp;sid=515</link>
<description>&lt;b&gt;Fyziologie erytropoezy a metabolismus železa&lt;/b&gt;&lt;/br&gt;
&lt;/br&gt;
VIDEOPREZENT&Aacute;CIA&lt;/br&gt;
&lt;/br&gt;
Doc. MUDr. Martin Vokurka CSc., &Uacute;stav patologick&eacute; fyziologie a Centrum experiment&aacute;ln&iacute; hematologie 1. LF UK, Praha</description>
</item>

<item>
<title>An&eacute;mie pri mnohopo&egrave;etnom myelome</title>
<link>http://www.hematology.sk/modules.php?name=News&amp;file=article&amp;sid=514</link>
<description>&lt;b&gt;An&eacute;mia pri mnohopo&egrave;etnom myelome&lt;/b&gt;&lt;/br&gt;
Patofyziol&oacute;gia a lie&egrave;ba&lt;/br&gt;
&lt;/br&gt;
Miriam Ladick&aacute;&lt;/br&gt;
Bratislava&lt;/br&gt;
&lt;/br&gt;
Patofyziol&oacute;gia, lie&egrave;ba, toxicita a špecifik&aacute; lie&egrave;by
</description>
</item>

<item>
<title>AN&Eacute;MIE, HEMOCHROMAT&Oacute;ZA</title>
<link>http://www.hematology.sk/modules.php?name=News&amp;file=article&amp;sid=513</link>
<description>&lt;b&gt;AN&Eacute;MIE II., HEMOCHROMAT&Oacute;ZA&lt;/b&gt;&lt;/br&gt;
&lt;/br&gt;
&Uacute;STAV PATOLOGICK&Eacute; FYZIOLOGIE 1.LF UK V PRAZE&lt;/br&gt;
&lt;/br&gt;
Patofyziologia, diagnostika a lie&egrave;ba an&eacute;mie</description>
</item>

</channel>
</rss>
